A New Hampshire man fought for the chance at a pig kidney transplant, spending months getting into good enough shape to be part of a small pilot study of a highly experimental treatment. His effort pa ...

February 14th is not only a day of love but also National Donor Day and one Chicopee couple has a special connection.

Shares of DaVita Inc (NYSE: DVA) are trading lower on Friday. The company's stock lost 11.1% as of market close but lost as ...

In a powerful act of love and sacrifice, Julie Malliet donated her kidney to her husband, Dave, who had been battling chronic kidney disease for years.

DaVita shares fell after the company's 2025 earnings missed expectations and Berkshire Hathaway sold shares in the company. The stock declined 10% to $158.96 on Friday, though it is up about 30% over ...

What Happened? Shares of dialysis provider DaVita Inc. (NYSE:DVA) fell 14% in the morning session after the company reported ...

The content of the Benesch, Friedlander, Coplan & Aronoff LLP Dialysis & Nephrology Digest is for general information purposes only. It does not constitute legal advice or create an ...

DaVita shares were tumbling 13.5% Friday to lead S&P 500 decliners, after Warren Buffett’s Berkshire Hathaway pared its stake ...

Researchers develop graphene-based dialysis membranes that enhance filtration efficiency while reducing protein loss for improved treatment.

A Vanderbilt-led research team has made a significant breakthrough in developing advanced dialysis membranes using atomically thin materials like graphene. These innovative membranes, called ...

In terms of intangible assets, DaVita has built the largest network of dialysis clinics in the US over several decades, based in part on its brand and reputation for high-quality services, extensive ...

Race may play a role in the waitlist experience, allograft quality and transplant outcomes of patients with autosomal ...